HF
SNTI icon

HRT Financial’s Senti Biosciences Holdings SNTI Stock Holding History

HRT Financial’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,844
Closed -$12K – 5259
2026
Q1 		$12K Buy
+14,844
New +$14.4K ﹤0.01% 3621
2024
Q3 		– Sell
-1,251
Closed -$3K – 3080
2024
Q2 		$3K Buy
+1,251
New +$4.05K ﹤0.01% 2068
2022
Q2 		– Sell
-2,938
Closed -$290K – 3672
2022
Q1 		$290K Sell
2,938
-196
-6% -$19.3K ﹤0.01% 2258
2021
Q4 		$309K Buy
+3,134
New +$312K ﹤0.01% 2251

Other funds holding SNTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's SNTI Position: Q2 2026 in Review

HRT Financial sold out of Senti Biosciences Holdings (SNTI) in Q2 2026, closing a stake of 14,844 shares — an estimated $12K sold.

HRT Financial first reported a position in SNTI in Q4 2021 and held it in 4 quarters. The position peaked at $309K in Q4 2021. 17 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • HRT Financial reported no remaining Senti Biosciences Holdings position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 14,844 Senti Biosciences Holdings shares in Q2 2026, an estimated $12K.
  • HRT Financial first reported a position in Senti Biosciences Holdings in Q4 2021 and held it in 4 quarters.
  • HRT Financial's Senti Biosciences Holdings position peaked at $309K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.